Actively Recruiting
MALE Mamm Organoids
Led by Regina Elena Cancer Institute · Updated on 2025-01-22
7
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
R
Regina Elena Cancer Institute
Lead Sponsor
S
San Giovanni Addolorata Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
CONDITIONS
Official Title
MALE Mamm Organoids
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men aged >18 years
- Patients with histologically confirmed breast cancer with or without synchronous metastases who will undergo the relevant surgical intervention
- Adequate biological material available for analyses
- Signing of the relevant informed consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS National Cancer Institute "Regina Elena"
Rome, Italy, 00144
Actively Recruiting
Research Team
G
Giovanni Blandino, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here